CD3 Antibody and IL‐2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response

E-ISSN： 2047-9980|4|3|JAHA.115.000750-JAHA.115.000750

ISSN： 2047-9980

Source： JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.4, Iss.3, 2015-03, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Regulatory Roles of Amino Acids in Immune Response

Current Rheumatology Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 252-258

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

By Tohra S.

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2449-2455

Springer Publishing Company

Access to resources Recommend Favorite

Response to Combination Therapy with Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C According to a TNF-α Promoter Polymorphism

Digestion, Vol. 68, Iss. 1, 2003-10 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with IIb 3 and M 2, in coronary stenting

By Fernandes L.S. Conde I.D. Wayne Smith C. Kansas G.S. Snapp K.R. Bennet N. Ballantyne C. McIntire L.V. O'Brian Smith E. Klem J.A. Mathew S. Frangogiannis N. Turner N.A. Maresh K.J. Kleiman N.S.

Thrombosis Research, Vol. 111, Iss. 3, 2003-01 ,pp. : 171-177

Elsevier

Access to resources Recommend Favorite

Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 426-433

Karger

Access to resources Recommend Favorite